Velcade: Phase II; Phase III for multiple myeloma (MM)

MLNM began an open-label U.S. Phase II trial in up to 175 patients with refractory metastatic colorectal cancer who have progressed following ?2 chemotherapy regimens. Up to 75 patients will receive V...